Recombinant CA 19-9 anticorps
-
- Antigène Voir toutes CA 19-9 Anticorps
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
- Type d'anticorp
- Recombinant Antibody
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CA 19-9 est non-conjugé
-
Application
- Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Purification
- Protein A affinity
- Immunogène
- Purified human protein used as the immunogen for the recombinant CA19-9 antibody.
- Clone
- CA19-9-1390R
- Isotype
- IgG kappa
- Top Product
- Discover our top product CA 19-9 Anticorps primaire
-
-
- Indications d'application
-
Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 2-4 μg/million cells in 0.1ml,Immunofluorescence: 5-10 μg/mL,Immunohistochemistry (FFPE): 5-10 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)
- Restrictions
- For Research Use only
-
- Concentration
- 1 mg/mL
- Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
- Agent conservateur
- Azide free
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store the recombinant CA19-9 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
- Antigène
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
- Autre désignation
- CA19-9 (CA 19-9 Produits)
- Sujet
- CA19-9, a carbohydrate epitope expressed on a high MW (>400 kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.
-